|
Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) Clinical research trials and Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate). Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) clinical trial. Subjects often receive the most expert healthcare possible for their Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate) condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)  Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
For Condition: Benign Prostatic Hypertrophy,Benign Prostatic Hyperplasia,Prostate Disease,BPH
Status: Recruiting
Sponsor(s): American Medical Systems ,
Synopsis: Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men will be enrolled in the study. Qualifying patients will receive one of three possible doses of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month, 3-months, and 6-months following treatment.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Historical Control, Parallel Assignment
Minimum Age/Maximum Age: 50 Years/80 Years
Genders: Male
Protocol Entry Criteria: Eligible patients are 50 to 80-year-old men who have experienced some or all of the following urinary symptoms for at least 6 months: - frequent or urgent need to urinate - difficulty starting their urinary stream - interruption of their urinary stream - feeling of incomplete emptying of bladder after urinating - interruption of sleep due to the urge to urinate Patients should have tried oral medication for their condition in the past, and be willing to discontinue any current BPH medications for a period of time before undergoing study treatment. They should be in good general health and have no previous surgery, or other procedure(s) intended to reduce prostate size.
Total Enrollment: 150
Location and Contact Information:
Stanford University Health Services *Recruiting*
Stanford, California, 94305
United States
Recruiting Nushin Namazi 650-498-4240
Oregon Urology Specialists *Recruiting*
Eugene, Oregon, 97401
United States
Recruiting Tamara Whittle 541-284-5508
Urological Sciences Research Foundation *Recruiting*
Culver City, California, 90230
United States
Recruiting Research Office 310-838-6347
Albany Medical Center *Recruiting*
Albany, New York, 12208-3499
United States
Recruiting Brenda Romeo 518-262-8579
Naval Medical Center *Recruiting*
San Diego, California, 83739
United States
Recruiting Terry Rogers 619-532-6781
Neil Baum, M.D. *Recruiting*
New Orleans, Louisiana, 70115
United States
Recruiting Kati Mencel 504-891-8454
University of Vermont *Recruiting*
Burlington, Vermont, 05403
United States
Recruiting Martha Bunnell 802-847-6108
Additional Information:
Study ID Numbers: AMS002;
Study Start Date: March 2002
Record last reviewed: July 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00037141
Other Benign Prostatic Hyperplasia Studies:
1. Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
Related Studies:
Other Benign Prostatic Hyperplasia Clinical Trials
Other Louisiana Clinical Trials
Other New Orleans Clinical Trials
Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
|
|
|
|
|
|
|
|
